Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoid Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02336048
What this trial is testing

A Study Evaluating the Safety of Tocilizumab in Addition to Standard of Care Premedication Given Before Obinutuzumab + Chlorambucil in Participants With Untreated B-Cell Chronic Lymphocytic Leukemia (B-CLL) and Comorbidities

Who this might be right for
B-Cell Chronic Lymphocytic Leukemia
Hoffmann-La Roche 38
Testing effectiveness (Phase 2)WithdrawnNCT02677948
What this trial is testing

Multicenter Study of Pacritinib Combined With Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

Who this might be right for
Chronic Lymphocytic LeukemiaLymphoma, Small Lymphocytic
University of Michigan Rogel Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06810778
What this trial is testing

Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
T-cell-prolymphocytic LeukemiaCutaneous T-Cell Lymphoma Refractory
Jonsson Comprehensive Cancer Center 12
Not applicableUnknownNCT05360758
What this trial is testing

Ibrutinib Adapted to Response in Patients With CLL

Who this might be right for
Chronic Lymphocytic Leukemia
Grupo Argentino de Tratamiento de la Leucemia Aguda 80
Testing effectiveness (Phase 2)Looking for participantsNCT06533748
What this trial is testing

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma
St. Jude Children's Research Hospital 128
Not applicableUnknownNCT06334835
What this trial is testing

Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.

Who this might be right for
Acute Lymphoblastic Leukemia, Pediatric
IRCCS SYNLAB SDN 20
Testing effectiveness (Phase 2)WithdrawnNCT01670084
What this trial is testing

Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+2 more
Mayo Clinic
Early research (Phase 1)Study completedNCT00019838
What this trial is testing

UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Ended earlyNCT00568633
What this trial is testing

Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML

Who this might be right for
Leukemia, MyeloidLeukemiaAcute Myeloid Leukemia (AML)
Stanford University 58
Not applicableNot Yet RecruitingNCT07476378
What this trial is testing

Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies

Who this might be right for
Lymphoma, Large B-Cell, Diffuse (DLBCL)Lymphoma, FollicularLymphoma, Mantle-Cell+3 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 69
Not applicableLooking for participantsNCT07288515
What this trial is testing

Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus

Who this might be right for
Chronic Lymphocytic Leukemia
AstraZeneca 50
Early research (Phase 1)Looking for participantsNCT03595917
What this trial is testing

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaChronic Myeloid Leukemia (CML) in Lymphoid Blast CrisisPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL
Marlise Luskin, MD 40
Not applicableWithdrawnNCT04322084
What this trial is testing

Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
St. Jude Children's Research Hospital
Not applicableNot Yet RecruitingNCT07809984
What this trial is testing

Prevention of Oral Mucositis in Adults in With Hematologic Malignancy

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+1 more
Wake Forest University Health Sciences 206
Early research (Phase 1)Study completedNCT00001249
What this trial is testing

Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac

Who this might be right for
Leukemia, T-CellLymphoma, T-Cell, Cutaneous
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Study completedNCT00103285
What this trial is testing

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia
Children's Oncology Group 5,377
Not applicableStudy completedNCT00890435
What this trial is testing

Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaUnspecified Adult Solid Tumor, Protocol Specific+1 more
Children's Oncology Group 53
Testing effectiveness (Phase 2)Study completedNCT00724984
What this trial is testing

Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma

Who this might be right for
LymphomaHodgkin DiseaseLymphoma, Non-Hodgkin
Pharmacyclics LLC. 55
Not applicableStudy completedNCT00481858
What this trial is testing

Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis

Who this might be right for
Chronic Lymphocytic Leukemia
KineMed 150
Not applicableUnknownNCT00710632
What this trial is testing

Screening to Predict Weight Loss in Patients With Cancer

Who this might be right for
CachexiaGastrointestinal CancerHematopoietic/Lymphoid Cancer+2 more
Queen's Medical Center 220
Next Page